Evidence map›Paper›PMID 29472381›Full record

ArticleJournal of lipid research2018

Deactivation of 12(S)-HETE through (ω-1)-hydroxylation and β-oxidation in alternatively activated macrophages.

Tamas Kriska, Michael J Thomas, John R Falck, William B Campbell

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Tamas KriskaDepartment of Pharmacology and Toxicology,* Medical College of Wisconsin, Milwaukee, WI 53226. Electronic address: tkriska@mcw.edu.
Michael J ThomasDepartment of Pharmacology and Toxicology,* Medical College of Wisconsin, Milwaukee, WI 53226.
John R FalckDepartment of Biochemistry,† University of Texas Southwestern Medical Center, Dallas, TX 75390.
William B CampbellDepartment of Pharmacology and Toxicology,* Medical College of Wisconsin, Milwaukee, WI 53226.
Medical College of Wisconsin · USThe University of Texas Southwestern Medical Center · US

Funding

Endothelial Lipoxygenase Metabolites and Vascular ToneR01HL103673 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI CAMPBELL, WILLIAM BRYSON · 2011 to 2014
$1.5M
Substance P: A central mediator of cardiac fibrosis and diastolic dysfunctionR01HL132908 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI CAMPBELL, WILLIAM BRYSON · 2017 to 2020
$1.4M
Substance P: A central mediator of cardiac fibrosis and diastolic dysfunctionR56HL132908 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LEVICK, SCOTT P · 2016 to 2016
$385k
NHLBI NIH HHS R01 HL103673NHLBI NIH HHS R01 HL132908NHLBI NIH HHS R56 HL132908
6 · The paper itself

Abstract

Polarization of macrophages to proinflammatory M1 and to antiinflammatory alternatively activated M2 states has physiological implications in the development of experimental hypertension and other pathological conditions. 12/15-Lipoxygenase (12/15-LO) and its enzymatic products 12(S)- and 15(S)-hydroxyeicosatetraenoic acid (HETE) are essential in the process since disruption of the gene encoding 12/15-LO renders the mice unsusceptible to hypertension. The objective was to test the hypothesis that M2 macrophages catabolize 12(S)-HETE into products that are incapable of promoting vasoconstriction. Cultured M2 macrophages metabolized externally added [

Indexed as

12-Hydroxy-5,8,10,14-eicosatetraenoic AcidAnimalsHydroxylationMacrophagesMaleMiceMice, Inbred C57BLOxidation-Reduction12-Hydroxy-5,8,10,14-eicosatetraenoic Acid12/15-lipoxygenase12(S)-HETE metabolismangiotensin IIcytochrome P450

Identifiers

PMID29472381
PMCPMC5880500
OpenAlexW2787886338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.